Sung, H., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. 71(3), 209–249.
Castiglioni, A. (1947). A history of medicine. Book. https://doi.org/10.4324/9780429019883
Hanahan, D. (2022). Hallmarks of cancer: New dimensions. Cancer Discovery, 12(1), 31–46.
Article CAS PubMed Google Scholar
Pedmedical. Healthy cell. 2022; Available from: https://www.shutterstock.com/discover/stock-assets-uk-0220?c3apidt=p11180842815&gclid=CjwKCAjwhNWZBhB_EiwAPzlhNkuEWQgNIi53MLZ7pPjOlHI2burmAnSGE3NyvROPpvHk2zrj9nG3cRoCxwUQAvD_BwE&gclsrc=aw.ds&kw=shutterstock.
Clinic, C. Carcinoma. 2019; Available from: https://my.clevelandclinic.org/health/diseases/23180-carcinoma#:~:text=Carcinoma%20is%20cancer%20that%20forms,head%20and%20neck%20are%20carcinomas.
Selchick, F. Cancer: Types, causes, prevention, and more. 2022; Available from: https://www.healthline.com/health/cancer#:~:text=Types%20of%20cancer&text=Carcinoma%20is%20a%20cancer%20that,cancers%20of%20the%20immune%20system.
Institute, N.C. What Is Cancer? 2021; Available from: https://www.cancer.gov/about-cancer/understanding/what-is-cancer#:~:text=Cancer%20is%20a%20disease%20caused,are%20also%20called%20genetic%20changes.
Cooper, J. L., & Robinson, P. (2000). The argument for making large classes seem small. New Directions for Teaching and Learning, 2000(81), 5–16.
Editorial. (2021). Advancing cancer therapy. Nature Cancer, 2(3), 245–246. https://doi.org/10.1038/s43018-021-00192-x
Jain, R. K., & Stylianopoulos, T. (2010). Delivering nanomedicine to solid tumors. Nature Reviews Clinical Oncology, 7(11), 653–664.
Article CAS PubMed PubMed Central Google Scholar
Hu, J.C.-M., & Zhang, L. (2009). Therapeutic nanoparticles to combat cancer drug resistance. Current Drug Metabolism, 10(8), 836–841.
Article CAS PubMed Google Scholar
Peer, D., et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, 2(12), 751–760.
Article CAS PubMed Google Scholar
Naud, C., et al. (2020). Cancer treatment by magneto-mechanical effect of particles, a review. Nanoscale Advances, 2(9), 3632–3655.
Article CAS PubMed PubMed Central Google Scholar
Murphy, C. J., et al. (2015). Biological responses to engineered nanomaterials: Needs for the next decade. ACS Central Science, 1(3), 117–123.
Article CAS PubMed PubMed Central Google Scholar
Morton, J. (1997). Reviews. Thesis Eleven, 51(1), 131–132.
Ghossain, A., & Ghossain, M. A. (2009). History of mastectomy before and after Halsted. Le Journal medical libanais. The Lebanese medical journal, 57(2), 65–71.
Sankaranarayanan, R., et al. (2013). Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala India. Oral Oncology, 49(4), 314–321.
Wang, K., & Tepper, J. E. (2021). Radiation therapy-associated toxicity: Etiology, management, and prevention. CA: A Cancer Journal for Clinicians, 71(5), 437–454.
Bird, S. M. (2015). The 1959 meeting in Vienna on controlled clinical trials–A methodological landmark. Journal of the Royal Society of Medicine, 108(9), 372–375.
Article PubMed PubMed Central Google Scholar
Cho, B. (2018). Intensity-modulated radiation therapy: A review with a physics perspective. Radiation Oncology Journal, 36(1), 1–10.
Article PubMed PubMed Central Google Scholar
Goodman, L. S., et al. (1946). Nitrogen mustard therapy: Use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for hodgkin’s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. Journal of the American Medical Association, 132(3), 126–132.
Article CAS PubMed Google Scholar
Farber, S., et al. (1948). Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). New England Journal of Medicine, 238(23), 787–793.
Article CAS PubMed Google Scholar
Hitchings, G. H., et al. (1950). Antagonists of nucleic acid derivatives: I The Lactobacillus casei model. Journal of Biological Chemistry, 183(1), 1–9.
De Rooij, J. D., Zwaan, C. M., & van den Heuvel-Eibrink, M. (2015). Pediatric AML: From biology to clinical management. Journal of clinical medicine, 4(1), 127–149.
Article PubMed PubMed Central Google Scholar
Kim, H. (2020). Treatments for children and adolescents with AML. Blood research, 55(S1), S5–S13.
Hermann, P. C., et al. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 1(3), 313–323.
Article CAS PubMed Google Scholar
Slats, A., et al. (2005). Causes of death–other than progressive leukemia–in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): The Dutch Childhood Oncology Group experience. Leukemia, 19(4), 537–544.
Article CAS PubMed Google Scholar
Bista, R., et al. (2017). Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells. Journal of Experimental & Clinical Cancer Research, 36(1), 1–14.
Aleem, E., & Arceci, R. J. (2015). Targeting cell cycle regulators in hematologic malignancies. Frontiers in cell and developmental biology, 3, 16.
Article PubMed PubMed Central Google Scholar
Lee, Y. T., Tan, Y. J., & Oon, C. E. (2018). Molecular targeted therapy: Treating cancer with specificity. European journal of pharmacology, 834, 188–196.
Article CAS PubMed Google Scholar
Yan, L., Rosen, N., & Arteaga, C. (2011). Targeted cancer therapies. Chinese journal of cancer, 30(1), 1.
Article PubMed PubMed Central Google Scholar
Mansour, M. A., Caputo, V. S., & Aleem, E. (2021). Highlights on selected growth factors and their receptors as promising anticancer drug targets. The International Journal of Biochemistry & Cell Biology, 140, 106087.
Nadukkandy, A. S., et al. (2022). Tracing new landscapes in the arena of nanoparticle-based cancer immunotherapy. Frontiers in Nanotechnology, 4, 911063.
Pankhurst, Q. A., et al. (2003). Applications of magnetic nanoparticles in biomedicine. Journal of physics D: Applied physics, 36(13), R167.
Cheng, Y., et al. (2014). Multifunctional nanoparticles for brain tumor imaging and therapy. Advanced drug delivery reviews, 66, 42–57.
Article CAS PubMed Google Scholar
Stephen, Z. R., Kievit, F. M., & Zhang, M. (2011). Magnetite nanoparticles for medical MR imaging. Materials Today, 14(7–8), 330–338.
Article CAS PubMed Google Scholar
Jin, R., et al. (2014). Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: Design considerations and clinical applications. Current opinion in pharmacology, 18, 18–27.
Article CAS PubMed Google Scholar
Arruebo, M., et al. (2007). Magnetic nanoparticles for drug delivery. Nano Today, 2(3), 22–32.
Mody, V. V., et al. (2014). Magnetic nanoparticle drug delivery systems for targeting tumor. Applied Nanoscience, 4(4), 385–392.
Sun, C., Lee, J. S., & Zhang, M. (2008). Magnetic nanoparticles in MR imaging and drug delivery. Advanced drug delivery reviews, 60(11), 1252–1265.
Article CAS PubMed PubMed Central Google Scholar
Gobbo, O. L., et al. (2015). Magnetic nanoparticles in cancer theranostics. Theranostics, 5(11), 1249.
Article CAS PubMed PubMed Central Google Scholar
Gao, Y., et al. (2015). Emerging translational research on magnetic nanoparticles for regenerative medicine. Chemical Society Reviews, 44(17), 6306–6329.
Article CAS PubMed Google Scholar
Zhang, Q., et al. (2017). Large-scale immuno-magnetic cell sorting of T cells based on a self-designed high-throughput system for potential clinical application. Nanoscale, 9(36), 13592–13599.
Article CAS PubMed Google Scholar
Cartmell, S., et al. (2005). Use of magnetic particles to apply mechanical forces for bone tissue engineering purposes. in Journal of Physics: Conference Series. IOP Publishing.
Sanchez, C., et al. (2014). Targeting a G-protein-coupled receptor overexpressed in endocrine tumors by magnetic nanoparticles to induce cell death. ACS Nano, 8(2), 1350–1363.
Article CAS PubMed Google Scholar
Kafrouni, L., & Savadogo, O. (2016). Recent progress on magnetic nanoparticles for magnetic hyperthermia. Progress in Biomaterials, 5(3), 147–160.
留言 (0)